Similar articles for PMID: 27390350

Year	Number of Results
2003	1
2006	2
2007	5
2008	6
2009	6
2010	10
2011	6
2012	13
2013	18
2014	11
2015	13
2016	22
2017	21
2018	39
2019	31
2020	30
2021	38
2022	23
2023	8
2024	0

1

Bortezomib Treatment Sensitizes Oncolytic HSV-1-Treated Tumors to NK Cell Immunotherapy.

Yoo JY, Jaime-Ramirez AC, Bolyard C, Dai H, Nallanagulagari T, Wojton J, Hurwitz BS, Relation T, Lee TJ, Lotze MT, Yu JG, Zhang J, Croce CM, Yu J, Caligiuri MA, Old M, Kaur B. Yoo JY, et al. Clin Cancer Res. 2016 Nov 1;22(21):5265-5276. doi: 10.1158/1078-0432.CCR-16-1003. Epub 2016 Jul 7. Clin Cancer Res. 2016. PMID: 27390350 Free PMC article.

2

Immunotherapy Gone Viral: Bortezomib and oHSV Enhance Antitumor NK-Cell Activity.

Suryadevara CM, Riccione KA, Sampson JH. Suryadevara CM, et al. Clin Cancer Res. 2016 Nov 1;22(21):5164-5166. doi: 10.1158/1078-0432.CCR-16-1666. Epub 2016 Aug 12. Clin Cancer Res. 2016. PMID: 27521450 Free PMC article.

3

Bortezomib-induced unfolded protein response increases oncolytic HSV-1 replication resulting in synergistic antitumor effects.

Yoo JY, Hurwitz BS, Bolyard C, Yu JG, Zhang J, Selvendiran K, Rath KS, He S, Bailey Z, Eaves D, Cripe TP, Parris DS, Caligiuri MA, Yu J, Old M, Kaur B. Yoo JY, et al. Clin Cancer Res. 2014 Jul 15;20(14):3787-98. doi: 10.1158/1078-0432.CCR-14-0553. Epub 2014 May 9. Clin Cancer Res. 2014. PMID: 24815720 Free PMC article.

4

A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases.

Chen X, Han J, Chu J, Zhang L, Zhang J, Chen C, Chen L, Wang Y, Wang H, Yi L, Elder JB, Wang QE, He X, Kaur B, Chiocca EA, Yu J. Chen X, et al. Oncotarget. 2016 May 10;7(19):27764-77. doi: 10.18632/oncotarget.8526. Oncotarget. 2016. PMID: 27050072 Free PMC article.

5

The Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor Microenvironment.

Meisen WH, Wohleb ES, Jaime-Ramirez AC, Bolyard C, Yoo JY, Russell L, Hardcastle J, Dubin S, Muili K, Yu J, Caligiuri M, Godbout J, Kaur B. Meisen WH, et al. Clin Cancer Res. 2015 Jul 15;21(14):3274-85. doi: 10.1158/1078-0432.CCR-14-3118. Epub 2015 Mar 31. Clin Cancer Res. 2015. PMID: 25829396 Free PMC article.

6

Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus-1 with Integrin β1 Blocking Antibody OS2966.

Lee TJ, Nair M, Banasavadi-Siddegowda Y, Liu J, Nallanagulagari T, Jaime-Ramirez AC, Guo JY, Quadri H, Zhang J, Bockhorst KH, Aghi MK, Carbonell WS, Kaur B, Yoo JY. Lee TJ, et al. Mol Cancer Ther. 2019 Jun;18(6):1127-1136. doi: 10.1158/1535-7163.MCT-18-0953. Epub 2019 Mar 29. Mol Cancer Ther. 2019. PMID: 30926634 Free PMC article.

7

Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1.

Thomas S, Kuncheria L, Roulstone V, Kyula JN, Mansfield D, Bommareddy PK, Smith H, Kaufman HL, Harrington KJ, Coffin RS. Thomas S, et al. J Immunother Cancer. 2019 Aug 10;7(1):214. doi: 10.1186/s40425-019-0682-1. J Immunother Cancer. 2019. PMID: 31399043 Free PMC article.

8

Oncolytic HSV therapy increases trametinib access to brain tumors and sensitizes them in vivo.

Yoo JY, Swanner J, Otani Y, Nair M, Park F, Banasavadi-Siddegowda Y, Liu J, Jaime-Ramirez AC, Hong B, Geng F, Guo D, Bystry D, Phelphs M, Quadri H, Lee TJ, Kaur B. Yoo JY, et al. Neuro Oncol. 2019 Sep 6;21(9):1131-1140. doi: 10.1093/neuonc/noz079. Neuro Oncol. 2019. PMID: 31063549 Free PMC article.

9

Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV.

Yoo JY, Pradarelli J, Haseley A, Wojton J, Kaka A, Bratasz A, Alvarez-Breckenridge CA, Yu JG, Powell K, Mazar AP, Teknos TN, Chiocca EA, Glorioso JC, Old M, Kaur B. Yoo JY, et al. Clin Cancer Res. 2012 Sep 15;18(18):4931-41. doi: 10.1158/1078-0432.CCR-12-0697. Epub 2012 Jul 2. Clin Cancer Res. 2012. PMID: 22753591 Free PMC article.

10

Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer.

Crespo-Rodriguez E, Bergerhoff K, Bozhanova G, Foo S, Patin EC, Whittock H, Buus R, Haider S, Muirhead G, Thway K, Newbold K, Coffin RS, Vile RG, Kim D, McLaughlin M, Melcher AA, Harrington KJ, Pedersen M. Crespo-Rodriguez E, et al. J Immunother Cancer. 2020 Aug;8(2):e000698. doi: 10.1136/jitc-2020-000698. J Immunother Cancer. 2020. PMID: 32759235 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

269 results

Results by year